Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 11 min 25 sec ago

Clear Catheter Systems, Inc. Changes Name to ClearFlow, Inc.

Wed, 03/12/2014 - 17:03
ANAHEIM, Calif.--(Healthcare Sales & Marketing Network)--Citing an expansion and rebranding exercise, Clear Catheter Systems, Inc. announced today it has changed its company name to ClearFlow, Inc. The new name reflects a renewed focus on helping clinician...
Devices, Surgery
ClearFlow, Clear Catheter Systems, PleuraFlow

Rosetta Genomics Provides Product Pipeline Update

Wed, 03/12/2014 - 17:00
Leveraging World-Class microRNA Biomarker Platform to Advance Proprietary Technologies in Diagnostics and Therapeutics; Plans to Launch One New Product Each Year Commencing in 2015 PRINCETON, NJ and REHOVOT, ISRAEL--(Healthcare Sales & Marketing Network...
Diagnostics
Rosetta Genomics, microRNA, molecular diagnostics

RTI Surgical(TM) Launches Two Natural Bone Grafting Solutions at AAOS Annual Meeting

Wed, 03/12/2014 - 16:56
NanOss® Bioactive 3D and map3™ Cellular Allogeneic Bone Graft are now available for U.S. distribution in the extremities and trauma markets ALACHUA, Fla.--(Healthcare Sales & Marketing Network)--RTI Surgical Inc. (RTI) (RTIX), a leading global sur...
Devices, Orthopaedic, Product Launch
RTI Surgical, NanOss, map3, Cellular Allogeneic Bone Graft

Cayenne Medical Announces Launch of The Mirror(TM) Partial Knee System

Wed, 03/12/2014 - 16:53
New Surgical Technique Simplifies the Procedure, Reducing Time and Cost While Providing True Kinematic Knee Balancing for the Patient SCOTTSDALE, Ariz., March 12, 2014 -- (Healthcare Sales & Marketing Network) -- Today at the Annual Academy of Orthopedi...
Devices, Orthopaedic, Product Launch
Cayenne Medical, The Mirror Partial Knee System, partial knee

Novimmune Appoints Andrew J. Oakley as CFO

Wed, 03/12/2014 - 16:48
GENEVA, March 12, 2014 -- (Healthcare Sales & Marketing Network) --Novimmune S.A announced today that Andrew J. Oakley has joined the company as Chief Financial Officer. Andrew Oakley, an Australian national, who most recently served as the CFO of Swis...
Biopharmaceuticals, Personnel
Novimmune, antibody

Pfizer Presents Detailed Results From Landmark Community-Acquired Pneumonia Immunization Trial In Adults (CAPiTA) Evaluating Efficacy Of Prevenar 13*

Wed, 03/12/2014 - 13:08
Study Findings, Presented at ISPPD, Demonstrate that Prevenar 13 Can Prevent Vaccine-Type Community-Acquired Pneumonia NEW YORK--(Healthcare Sales & Marketing Network)--Pfizer Inc. (PFE) today presented detailed results of the Community-Acquired Pneumon...
Biopharmaceuticals
Pfizer, Prevenar 13, community-acquired pneumonia

Toshiba’s Exclusive CT Myocardial Perfusion Helps Produce Faster and Safer Cardiac Diagnoses

Wed, 03/12/2014 - 12:58
Industry’s Best Solution Allows Clinicians to Visualize Myocardial Ischemia with CT TUSTIN, Calif.--(Healthcare Sales & Marketing Network)--To improve cardiac diagnoses with simplified dose reduction technology, Toshiba announces the FDA clearance of it...
Devices, Radiology, Cardiology, FDA
Toshiba America Medical Systems, CT Myocardial Perfusion, CT, Aquilion

KARL STORZ Announces Commercial Release of the Flex-Xc Flexible Uretero-Renoscope

Tue, 03/11/2014 - 15:16
EL SEGUNDO, Calif.--(Healthcare Sales & Marketing Network)--KARL STORZ Endoscopy-America, Inc., a leader in endoscopy and operating room integration solutions, is pleased to announce the commercial release of its Flex-Xc Flexible Uretero-Renoscope. The Fle...
Devices, Urology, Product Launch
KARL STORZ Endoscopy, Flex-Xc, Uretero-Renoscope

BioElectronics Appoints Deepak Kotak, MD, Esq as Executive Vice President

Tue, 03/11/2014 - 15:14
Dr. Kotak will lead the expansion of the company's medical line into new markets FREDERICK, Md., March 11, 2014 -- (Healthcare Sales & Marketing Network) -- BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices has...
Devices, Personnel
BioElectronics Corp, ActiPatch

Lumena Pharmaceuticals Raises $45 Million in Series B Financing

Tue, 03/11/2014 - 12:13
Funding to support clinical development of treatments for rare cholestatic liver diseases and nonalcoholic steatohepatitis SAN DIEGO, March 11, 2014 -- (Healthcare Sales & Marketing Network) -- Lumena Pharmaceuticals (Lumena), a biopharmaceutical compa...
Biopharmaceuticals, Venture Capital
Lumena Pharmaceuticals, cholestatic liver disease, steatohepatitis

Exosome Diagnostics Raises $27 Million in Series B Financing

Tue, 03/11/2014 - 12:09
NEW YORK, March 11, 2014 -- (Healthcare Sales & Marketing Network) -- Exosome Diagnostics today announced the initial close of its Series B financing round with the raising of $27 million. Proceeds will be used to advance development of the Company's prop...
Diagnostics, Venture Capital
Exosome Diagnostics

AngioDynamics Receives Expanded FDA Clearance for AngioVac

Tue, 03/11/2014 - 12:04
ALBANY, N.Y., March 11, 2014 -- (Healthcare Sales & Marketing Network) -- AngioDynamics (ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the...
Devices, Cardiology, FDA
AngioDynamics, AngioVac cannula, extracorporeal bypass

Sorrento Therapeutics Appoints Mark Durand to its Board of Directors

Tue, 03/11/2014 - 12:01
SAN DIEGO, March 11, 2014 -- (Healthcare Sales & Marketing Network) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), a late-stage clinical oncology company developing new treatments for cancer and associated pain, today announced the addition of i...
Biopharmaceuticals, Oncology, Personnel
Sorrento Therapeutics, Cynviloq, paclitaxel

Caisson Biotech Expands HEPtune(TM) Drug Delivery Deal with Novo Nordisk

Tue, 03/11/2014 - 11:57
Patented technology could bring up to $167 million in milestone payments plus future long-term residual royalties to Caisson. OKLAHOMA CITY and AUSTIN, Texas, March 11, 2014 -- (Healthcare Sales & Marketing Network) -- Caisson Biotech, L.L.C., a biopha...
Biopharmaceuticals, Drug Delivery, Licensing
Caisson Biotech, Novo Nordisk, HEPtune, heparosan

Bayer and Onyx Report Phase 3 Study Results of NEXAVAR(R) (sorafenib) as Adjuvant Treatment for Patients with Liver Cancer Who Have Undergone Surgery or Local Ablation

Tue, 03/11/2014 - 11:51
WHIPPANY, N.J., THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif., March 11, 2014 -- (Healthcare Sales & Marketing Network) -- Bayer HealthCare Pharmaceuticals Inc. and Onyx Pharmaceuticals, Inc., an Amgen subsidiary (AMGN), today announced that a Pha...
Biopharmaceuticals, Oncology
Bayer HealthCare Pharmaceuticals, Onyx Pharmaceuticals, Amgen, NEXAVAR, HCC

Freedom Knee(R) Revision Knee System Receives US FDA 510(k) Clearance Ahead of American Academy of Orthopaedic Surgeons (AAOS) Meeting

Mon, 03/10/2014 - 19:35
Plymouth Meeting, PA (USA) and Andheri, Mumbai (India), March 10, 2014 -- (Healthcare Sales & Marketing Network) -- Maxx Orthopedics, Inc. a subsidiary of Maxx Medical, Pvt. Ltd., a rapidly expanding global orthopedics device company, today announced that ...
Devices, Orthopaedic, FDA
Maxx Medical, Maxx Orthopedics, Revision knee

Minimally Invasive Devices Launches Robotic FloShield(TM) to Enhance Visibility During Robotic Surgery

Mon, 03/10/2014 - 18:52
COLUMBUS, Ohio, March 10, 2014 -- (Healthcare Sales & Marketing Network) -- Minimally Invasive Devices, Inc., an Ohio-based, venture-backed medical device company that specializes in optimizing the surgeon's vision during laparoscopic surgery, today annou...
Devices, Surgery, Product Launch
Minimally Invasive Devices Inc, Robotic FloShield, da Vinci, robotic surgery

Cardiovascular Systems Receives FDA Clearance for Low Profile, 60cm Diamondback Devices Designed to Expand the Treatment of Peripheral Artery Disease (PAD)

Mon, 03/10/2014 - 18:50
ST. PAUL, Minn.--(Healthcare Sales & Marketing Network)--Cardiovascular Systems, Inc. (CSII) (CSI), announced today it has received FDA clearance of its new Diamondback 360® 60cm Peripheral Orbital Atherectomy Systems (OAS) for the treatment of periphe...
Devices, Interventional, FDA
Cardiovascular Systems, Diamondback, Atherectomy, Peripheral Arterial Disease

Intra-Cellular Therapies Announces the Appointment of Juan Sanchez, M.D., as Vice President of Corporate Communications and Investor Relations

Mon, 03/10/2014 - 18:47
NEW YORK, March 10, 2014 -- (Healthcare Sales & Marketing Network) -- Intra-Cellular Therapies, Inc. (ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced the appointment...
Biopharmaceuticals, Neurology, Personnel
Intra-Cellular Therapies, schizophrenia

Stem Cell Therapeutics Strengthens its Board of Directors

Mon, 03/10/2014 - 18:45
Adds US industry veterans with broad financial and clinical expertise TORONTO, CANADA--(Healthcare Sales & Marketing Network) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS)(SCTPF), an immuno-oncology company developing cancer stem cell-related therape...
Biopharmaceuticals, Oncology, Personnel
Stem Cell Therapeutics Corp, stem cell, monoclonal antibody

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong